Agenus Inc. (AGEN)
NASDAQ·Healthcare·Biotechnology
$3.91
-4.52%
Mkt Cap $107.13M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | $28.10M | $34.20M | +21.73% | -$1.27 | $0.56 | +144.09% | — | — |
| Q4 2025 Nov 10, 2025 | $28.10M | $30.23M | +7.61% | $2.63 | $1.94 | -26.24% | — | — |
| Q3 2025 Aug 11, 2025 | $24.98M | $25.69M | +2.85% | -$0.78 | -$1.00 | -28.21% | — | — |
| Q2 2025 May 12, 2025 | $22.09M | $24.07M | +8.94% | -$1.61 | -$1.03 | +36.02% | — | — |
| Q1 2025 Mar 11, 2025 | $30.09M | $26.84M | -10.82% | -$2.36 | -$2.04 | +13.56% | — | — |
| Q4 2024 Nov 12, 2024 | $31.81M | $25.11M | -21.06% | -$2.33 | -$3.08 | -32.19% | — | — |
| Q3 2024 Aug 8, 2024 | $61.48M | $23.51M | -61.76% | -$1.44 | -$2.52 | -75.00% | — | — |
| Q2 2024 May 7, 2024 | $39.27M | $28.00M | -28.69% | -$3.22 | -$3.04 | +5.59% | — | — |
| Q1 2024 Mar 14, 2024 | $47.05M | $83.80M | +78.11% | -$0.40 | -$2.60 | -550.00% | — | — |
| Q4 2023 Nov 7, 2023 | $47.05M | $24.31M | -48.32% | -$3.80 | -$3.20 | +15.79% | — | — |
| Q3 2023 Aug 8, 2023 | $24.12M | $25.30M | +4.88% | -$4.00 | -$4.00 | +0.00% | — | — |
| Q2 2023 May 9, 2023 | $22.98M | $22.90M | -0.34% | -$4.20 | -$4.40 | -4.76% | — | — |
| Q1 2023 Mar 14, 2023 | $17.83M | $28.39M | +59.20% | -$4.40 | -$4.80 | -9.09% | — | — |
| Q4 2022 Nov 8, 2022 | $20.69M | $22.77M | +10.05% | -$3.60 | -$3.80 | -5.56% | — | — |
| Q3 2022 Aug 9, 2022 | $18.70M | $20.93M | +11.93% | -$4.60 | -$3.40 | +26.09% | — | — |
| Q2 2022 May 10, 2022 | $11.80M | $25.94M | +119.82% | -$5.80 | -$3.80 | +34.48% | — | — |
| Q1 2022 Mar 1, 2022 | $37.74M | $20.26M | -46.31% | -$3.20 | -$5.20 | -62.50% | — | — |
| Q4 2021 Nov 9, 2021 | $183.11M | $252.95M | +38.14% | $9.20 | $13.80 | +50.00% | — | — |
| Q3 2021 Aug 9, 2021 | $10.73M | $10.73M | +0.00% | -$4.80 | -$7.40 | -54.17% | — | — |
| Q2 2021 May 6, 2021 | $13.23M | $11.72M | -11.43% | -$6.20 | -$5.40 | +12.90% | — | — |